Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 7/20 | 0.67 |
| ▸ | CAPN1 | P07384 | 3/20 | 0.64 |
| ▸ | CTSL | P07711 | 5/20 | 0.64 |
| ▸ | CTSB | P07858 | 3/20 | 0.64 |
| ▸ | CTSS | P25774 | 2/20 | 0.64 |
| ▸ | CAPN2 | P17655 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31094975 | 1.00 | CTSK (0.67) | CTSKCAPN1CTSLCTSBCTSS | |
| SCHEMBL31729514 | 0.96 | CAPN1 (0.68) | CTSKCAPN1CTSLCTSBCTSS | |
| SCHEMBL30643745 | 0.96 | CTSK (0.64) | CTSKCAPN1CTSLCTSBCTSS | |
| SCHEMBL14433713 | 0.95 | CTSK (0.64) | CTSKCAPN1CTSLCTSBCTSS | |
| SCHEMBL13589982 | 0.95 | CTSK (0.64) | CTSKCAPN1CTSLCTSBCTSS | |
| SCHEMBL16770328 | 0.91 | CTSK (0.65) | CTSKCAPN1CTSLCTSBCTSS | |
| SCHEMBL25406813 | 0.91 | CTSK (0.77) | CTSKCAPN1CTSLCTSBCTSS | |
| SCHEMBL8823918 | 0.91 | CTSK (0.77) | CTSKCAPN1CTSLCTSBCTSS | |
| SCHEMBL9697579 | 0.91 | MME (0.65) | CTSL | |
| SCHEMBL4872585 | 0.91 | CTSK (0.77) | CTSKCAPN1CTSLCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111246873-B | Optimized peptides for targeting human nerves and their use in image guided surgery, diagnosis and therapy delivery | 加利福尼亚大学董事会 | 2024-03-01 | — | — | CN | disclosed |
| CN-112996486-A | Local delivery of therapeutic agents comprising cell penetrating peptides for the treatment of age-related macular degeneration and other eye diseases | K·罗伊兹曼 | 2021-06-18 | — | — | CN | disclosed |
| EP-1626732-A2 | MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS | Theraptosis S.A. (FR) | 2006-02-22 | — | — | EP | disclosed |
| WO-2004103389-A2 | MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS | THERAPTOSIS SA (FR) | 2004-12-02 | — | — | WO | disclosed |